+ All Categories
Home > Documents > bradikard

bradikard

Date post: 02-Apr-2018
Category:
Upload: micija-cucu
View: 217 times
Download: 0 times
Share this document with a friend

of 186

Transcript
  • 7/27/2019 bradikard

    1/186

    BradycardiaHighlights

    Summary

    Overview

    Basics

    Definition

    EpidemiologyAetiology

    Pathophysiology

    Classification

    Prevention

    Screening

    Secondary

    Diagnosis

    History & examination

    Tests

    Differential

    Step-by-step

    GuidelinesCase history

    Treatment

    Details

    Step-by-step

    Guidelines

    Follow Up

    Recommendations

    Complications

    Prognosis

    Resources

    References

    Images

    Patient leaflets

    Credits

    Email

    Print

    Feedback

    Share

    Add to Portfolio

    Bookmark

    Add notes

    History & exam

    Key factors

    presence of risk factors

    pulse rate below 50 bpm

    dizziness/lightheadedness

    syncope

    fatigue

    http://bestpractice.bmj.com/best-practice/monograph/832/highlights.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/summary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/definition.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/epidemiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/aetiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/pathophysiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/classification.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/screening.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/secondary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/differential.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/case-history.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/recommendations.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/complications.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/prognosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/patient-leaflets.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/credits.htmlhttp://bestpractice.bmj.com/best-practice/emailfriend/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/feedback/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/share/832/highlights/overview.htmlhttp://portfolio.bmj.com/portfolio/add-to-portfolio.html?u=%3C;url%3Ehttp://bestpractice.bmj.com/best-practice/mybp/mybpSave.html?category=bookmark&dataKey=Bradycardia+-+Overview&dataValue=%2Fbest-practice%2Fmonograph%2F832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/summary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/definition.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/epidemiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/aetiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/pathophysiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/classification.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/screening.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/secondary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/differential.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/case-history.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/recommendations.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/complications.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/prognosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/patient-leaflets.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/credits.htmlhttp://bestpractice.bmj.com/best-practice/emailfriend/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/feedback/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/share/832/highlights/overview.htmlhttp://portfolio.bmj.com/portfolio/add-to-portfolio.html?u=%3C;url%3Ehttp://bestpractice.bmj.com/best-practice/mybp/mybpSave.html?category=bookmark&dataKey=Bradycardia+-+Overview&dataValue=%2Fbest-practice%2Fmonograph%2F832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.html
  • 7/27/2019 bradikard

    2/186

    exercise intolerance

    shortness of breath

    cannon a-waves in jugular venous pulse

    jugular venous distension

    Other diagnostic factors

    increased intracranial pressure

    abnormal heart sounds

    abdominal or lower extremity oedema

    hypotension

    mental status changes

    pallor

    extremities cool to touch

    hypothermia

    chest pain

    History & exam details

    Diagnostic tests

    1st tests to order

    12-lead ECG

    Holter monitoring

    event monitor

    exercise testing

    carotid sinus massage

    echocardiogram

    thyroid function tests

    basic metabolic panel

    cardiac markers

    serum digoxin level

    serum creatinine

    Tests to consider

    implantable-loop recorder

    tilt-table testing

    electrophysiology testing

    Diagnostic tests details

    Treatment details

    http://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.html
  • 7/27/2019 bradikard

    3/186

    Acute

    haemodynamically unstable

    pharmacotherapy

    temporary pacing

    haemodynamically stable: sinus node dysfunction

    reversible cause: asymptomatic or mild symptoms

    o treatment of underlying cause

    o theophylline

    reversible cause: severe symptoms

    o treatment of underlying cause + temporary pacing

    irreversible cause: asymptomatic or mild symptoms

    o reassurance

    irreversible cause: severe symptoms

    o permanent pacing

    haemodynamically stable: acquired AV block

    reversible cause: asymptomatic without indications for pacing

    o treatment of underlying cause

    reversible cause: symptomatic or indications for pacing

    o treatment of underlying cause + temporary pacing

    irreversible cause: asymptomatic without indications for pacing

    o reassurance

    irreversible cause: symptomatic or indications for pacing

    o permanent pacing

    hemodynamically stable: congenital AV block

    asymptomatic without indications for pacing

    o reassurance

    symptomatic or indications for pacing

    o permanent pacing

    haemodynamically stable: vagally mediated bradycardia

    carotid hypersensitivity syndrome

    o permanent pacing

    neurocardiogenic or vasovagal syncope

    o lifestyle modifications

  • 7/27/2019 bradikard

    4/186

    o pharmacotherapy

    o permanent pacing

    Treatment details

    Summary

    Any heart rhythm slower than 50 bpm, even if transient, owing to sinus node dysfunction and/or

    atrioventricular (AV) conduction abnormalities.

    Causes include intrinsic sinus node and AV nodal disease, or extrinsic influences, which may be

    reversible.

    Common symptoms include syncope, fatigue, and dizziness; however, the patient may be

    asymptomatic.

    Evaluation involves determining the association of symptoms with heart rate and an assessment of

    underlying cardiovascular conditions. ECG is the diagnostic test of choice.

    Patients with a reversible cause may not require long-term therapy; however, patients with non-

    reversible causes may require an implantable pacemaker with or without a defibrillator. Urgent treatment may

    include temporary pacing and drug interventions.

    Potentially life-threatening complications, including cardiovascular collapse and death, may occur.

    DefinitionWhile some consider bradycardia to be a heart rate

  • 7/27/2019 bradikard

    5/186

    tissue inflammation or infiltration, infections (e.g., typhoid fever, diphtheria,tuberculosis, toxoplasmosis, rheumatic fever, or viral myocarditis), orabnormal autonomic effects. Extrinsic causes include exposure to toxins(e.g., lead, black widow spider venom, or tricyclic antidepressant overdose),drugs (e.g., digoxin, beta-blockers, calcium-channel blockers, or class I or III

    antiarrhythmics), or electrolyte abnormalities.[3] [16]Some causes, such ashypothyroidism, electrolyte disorders, and those that are drug-induced, arereversible. Inferior wall myocardial infarction and increased intracranialpressure can also cause various types of bradycardia.

    High vagal tone in an otherwise healthy young adult is a common cause ofsinus bradycardia and Mobitz I (rarely Mobitz II) atrioventricular (AV) block.This may even manifest during sleep and may be exacerbated by sleepapnoea.

    Generalised conduction system disease related to calcification and fibrosis iscalled Lev's disease (or Lenegre-Lev syndrome) and is a cause of acquiredcomplete heart block. Lev's disease is seen most commonly in older peopleand is often described as senile degeneration of the conduction system.

    PathophysiologyThe cellular mechanisms are complex and interrelated. Failure of any one of these mechanisms can have an

    effect on heart rate. Normal cardiac electrical activation requires normal sinus node automaticity and effective

    AV node and His-Purkinje conduction. Anything that causes sinus node automaticity or conduction through the

    AV node and/or His-Purkinje system can cause bradycardia.

    Classification

    Clinical classification

    Bradycardia can be classified as asymptomatic or symptomatic.Asymptomatic patients often do not require treatment.

    Bradycardia classification

    Bradycardia can be classified according to the site of the conductiondisturbance.[3]

    Sinus node dysfunction

    Sinus bradycardia: heart rate below 50 bpm. It can be a normal finding, especially during rest or sleep,

    or can be abnormal and symptomatic.[4]

    Sinus nodal pauses/arrest: episodic, abrupt termination of sinus rhythm generally lasting longer than 3

    seconds. Episodes can last longer than 30 seconds. There can be haemodynamic collapse, loss of blood

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-16http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-16http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-4http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-4http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-4http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-16http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-4
  • 7/27/2019 bradikard

    6/186

    pressure, and/or loss of consciousness. The term sinus arrest is used generally for long sinus node pauses (i.e.,

    >5 seconds).[5]

    Sinus nodal exit block: sinus node continues to activate but electrical activation is delayed and either

    blocked completely or incompletely between the sinus node and the atria. There can be various levels of block

    (e.g., complete or intermittent block).[6]

    Tachycardia-bradycardia syndrome: occurs when there are episodic periods of tachycardia (usually

    atrial flutter, atrial fibrillation, or atrial tachycardia), followed by termination of the tachycardia leading to sinus

    arrest or long sinus pauses, followed by sinus bradycardia.[7]

    Chronotropic incompetence: a form of bradycardia in which the sinus rate does not accelerate

    appropriately with exercise.[8]

    Sick sinus syndrome: a condition in which sinus node dysfunction manifests as one of the above

    abnormalities and there is evidence of slowing of sinus node function. Although this is generally not due to

    autonomic abnormalities, they can contribute. Some patients have marked bradycardia owing to sinus node

    dysfunction only after medicines that slow the sinus node are initiated. Sick sinus syndrome has been associated

    with atrioventricular (AV) nodal conduction abnormalities and a high risk of systemic embolism.[9]AV conduction disturbance

    AV block occurs when atrial depolarisation fails to reach the ventricles orwhen atrial depolarisation is conducted with a delay.

    First-degree AV block: delay in AV conduction, such that the PR interval is over 0.2 seconds. During

    first-degree AV block, there is one-to-one conduction but there is delay in AV nodal conduction.[10] It is not

    necessarily associated with bradycardia but it may be associated with higher degrees of AV block and

    subsequent bradycardia or sinus node dysfunction.

    Second-degree AV block: periodic failure of conduction from the atria to the ventricles. This assumes

    that the atrial rate is regular. A blocked premature atrial beat is not second-degree AV block. There are different

    types:

    o Mobitz I: grouped beating with a constant PP interval, lengthening in the PR interval and

    changing (usually shortening) RR intervals with the cycle ending with a P-wave and not followed by a QRS

    complex. As the PR interval gradually prolongs, the RR interval tends to stay the same or shorten.[11]Also

    called Wenckebach AV block.

    o Mobitz II: associated with single non-conducted P-waves with a constant PP interval and

    constant PR intervals (no change in the PR above 0.025 seconds).[12]

    o 2:1 block: only one PR interval to examine before the blocked P-wave and 2 P-waves for every

    QRS complex. In most cases, it will change to Mobitz I or II. If there is an associated bundle branch block, this

    suggests block in the His-Purkinje system.

    o High-degree AV block: more than one sequentially blocked P-wave.[13]

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-13http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-13http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-13http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-13
  • 7/27/2019 bradikard

    7/186

    Third-degree AV block: occurs when there are no conducted impulses from the atria to the ventricles.

    Also called complete AV block. This may occur with regular atrial activity without conduction or with an atrial

    tachyarrhythmia.

    Paroxysmal AV block: normal AV nodal conduction followed by sudden block of AV conduction

    associated with a long pause and multiple blocked P-waves, with subsequent resumption of AV conduction. Thiscan be related to underlying AV nodal or His-Purkinje conduction anomalies or to abrupt parasympathetic

    activation causing block in AV nodal conduction. In the latter instance, there is often slowing in sinus activation.

    Vagotonic AV block: slowing of the sinus node with prolongation of the PR interval followed by AV block

    owing to transient abrupt increase in parasympathetic tone.

    Congenital complete heart block: usually associated with a narrow QRS complex escape rhythm arising

    in the AV node.

    Escape rhythms

    When the sinus rate slows or there is AV block, other cardiac structures canactivate owing to their intrinsic automaticity. The AV nodal rate tends to be 40to 60 bpm and the ventricular rate tends to be 20 to 40 bpm.

    Atrial rhythm: originates from atrial structures other than the sinus node during sinus bradycardia or

    sinus arrest.

    Junctional rhythm: escape rhythm when there is bradycardia or arrest of sinus node or atrial activation.

    Activation of the junction may occur with or without AV block.[14]

    Ventricular rhythm: an escape rhythm from the ventricles when there is AV block or sinus bradycardia.

    AV dissociation

    Atrial and ventricular activation occur from different pacemakers. Ventricular activation may be from

    junctional or infranodal automaticity. AV dissociation can occur in the presence of intact AV conduction,

    especially when rates of the pacemaker, either junctional or ventricular, exceed the atrial rate.

    The atria and ventricles do not activate in a synchronous fashion but beat independent of each other.

    Usually, the ventricular rate is the same or faster than the atrial rate. When the atrial rate is faster and the atria

    and ventricles are beating independently, complete heart block is present.

    AV dissociation can be complete or incomplete. When incomplete, some P-waves conduct and capture

    the ventricles but, if they do not, it is complete. Complete AV dissociation mimics AV block and has to do with P-

    wave timing in relation to independent ventricular activation.

    There are 2 types

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-14http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-14http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-14http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-14
  • 7/27/2019 bradikard

    8/186

    o Isorhythmic: when the atrial rate is the same (or nearly the same) as the ventricular rate but the

    P-wave is not conducted.

    o Interference: when P-waves and QRS rates are similar but, occasionally, the atria conduct to the

    ventricles.

    ScreeningScreening for bradycardia is not carried out normally because treatment is usually administered for symptomatic

    patients only.

    Patients may present with conditions that potentially predispose to bradycardia during routine clinic visits and

    these can be identified easily based on a review of the patient's medical history (e.g., hypothyroidism, medicines,

    and history of myocardial infarction). Treatment is not offered unless the vital signs (hypotension and

    bradycardia) suggest that the patient is, or may be at risk of, lightheadedness, syncope, or other complications.

    Screening ECGs and Holter monitoring may be considered for special patient populations, such as those with

    muscular dystrophies (e.g., myotonic dystrophy, Kearns-Sayre's syndrome, peronoeal muscular dystrophy, or

    limb-girdle muscular dystrophy), which affect the conduction system of the heart specifically. Findings of bundle-

    branch block and fascicular block with bradycardia in these patients, even though asymptomatic, should be

    followed-up aggressively because these patients can have unpredictable progression to complete heart block

    and sudden death.[35]

    Secondary preventionRegular evaluation and examinations are necessary, and patient reporting of

    suspicious symptoms is the best way to diagnose problems with bradycardia.Patients should guide practitioners regarding their symptoms and medicinesthat may be associated with bradycardia.

    History & examinationKey diagnostic factorshide allpresence of risk factors (common)

    Key risk factors include history of taking medicines known to cause bradycardia, age over 70 years,

    previous myocardial infarction, surgery, hypothyroidism, sleep apnoea, exposure to toxins,

    infections, infiltrative diseases, and electrolyte disorders.pulse rate below 50 bpm (common)

    Palpation of peripheral pulse or cardiac auscultation may reveal a slow, regular heart beat of below

    50 bpm or an irregular pulse of varying intensity.dizziness/lightheadedness (common)

    Occurs owing to bradycardia-induced cerebral hypoperfusion, especially in the setting of left

    ventricular dysfunction.syncope (common)

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35
  • 7/27/2019 bradikard

    9/186

    Syncope is possible with long sinus nodal pauses or very slow heart rates.

    Occurs owing to bradycardia-induced cerebral hypoperfusion, especially in the setting of left

    ventricular dysfunction.

    Common in patients with complete heart block and a very slow ventricular escape rhythm with left

    ventricular dysfunction and in patients with second-degree atrioventricular (AV) block.fatigue (common)

    Many patients complain of worsening fatigue.

    exercise intolerance (common)

    May be owing to sinus node, AV node, or His-Purkinje system disease.

    shortness of breath (common)

    May be owing to sinus node, AV node, or His-Purkinje system disease.

    cannon a-waves in jugular venous pulse (common)

    Patients with bradycardia secondary to complete heart block can have intermittent cannon a-waves

    in their jugular venous pulse noted, owing to atrial contraction against a closed tricuspid valve.

    Similarly, there may be a variable S1 during complete AV block.

    During a junctional or ventricular rhythm with 1:1 V-to-A conduction, there may be cannon a-waves

    for each heart beat.jugular venous distension (common)

    Owing to heart failure caused by bradycardia.

    Other diagnostic factorshide allincreased intracranial pressure (common)

    Sinus bradycardia can be noted as part of Cushing's triad (hypertension, bradycardia, and irregular

    respirations) related to raised intracranial pressure.

    abnormal heart sounds (uncommon)

    Because bradycardia can contribute to heart failure, patients may have a third heart sound and

    rales.abdominal or lower extremity oedema (uncommon)

    Owing to heart failure caused by bradycardia.

    hypotension (uncommon)

    Manifestation of poor cardiac output owing to bradycardia.

    mental status changes (uncommon)

    Manifestation of poor cardiac output owing to bradycardia.

    pallor(uncommon)

    Manifestation of poor cardiac output owing to bradycardia.

    extremities cool to touch (uncommon)

    Manifestation of poor cardiac output owing to bradycardia.

    hypothermia (uncommon)

    Asymptomatic or symptomatic sinus bradycardia may occur in association with hypothermia.

    chest pain (uncommon)

    Rare presentation of bradycardia.

  • 7/27/2019 bradikard

    10/186

    Risk factorshide all

    Strong

    use of known causative medications

    Class I antiarrythmics (sodium channel blockers such as quinidine, disopyramide, lidocaine,

    phenytoin, fleicanide, propafenone), class III antiarrhythmics (potassium channel blockers such as

    amiodarone, sotalol, dofetilide), digoxin, beta-blockers, and calcium-channel blockers can cause

    bradycardia.[3] The effect is often dose- and drug-level-dependent, which, in turn, will depend on

    factors affecting drug metabolism, such as patient age, renal function, and hepatic function.

    Other non-cardiac medicines that can cause bradycardia include: clonidine, calcium chloride,

    calcium gluconate, lithium, reserpine, methyldopa, opioids, benzatropine, paclitaxel, topical

    ophthalmic beta-blockers, phenytoin, cimetidine, thalidomide, dimethyl sulphoxide, topical

    ophthalmic acetylcholine, fentanyl, alfentanil, sufentanil, and cholinesterase inhibitors.

    Drugs that contribute to atrioventricular (AV) block and/or sinus node dysfunction may only be

    uncovering an underlying 'occult' problem.[17]age over 70 years

    Older patients are at greater risk for developing sinus node dysfunction and AV nodal disease,

    which are the major causes of bradycardia in this patient cohort.

    In general, bradycardia is related to degeneration of the conduction system and the sinus node and

    changes in autonomic tone, which tends to worsen with age.[9][18] [19] [20]recent myocardial infarction

    Acute myocardial infarction can cause bradycardia by causing conduction block in the AV node

    (inferior infarction) or the His-Purkinje system (anterior infarction).[3] [21] [22] [23] Sinus bradycardia and AV block owing to inferior infarction is often caused by the Bezold-Jarisch

    reflex (i.e., a transient increased vagal activation). Consequently, bradycardia following inferior

    infarction often resolves. Generally, the bradycardia caused by AV block in the His-Purkinje system

    owing to anterior wall myocardial infarction does not resolve.

    Acute thrombosis of a coronary artery supplying the sinus or AV node can cause bradycardia,

    although permanent AV block is generally caused by anterior infarction affecting the bundle of His.

    Common causes for sinus bradycardia and AV block in the setting of acute myocardial infarction

    include the use of beta-blockers, calcium-channel blockers, antiarrhythmics, and morphine; high

    levels of pain; increased vagal tone (especially following inferior infarction); and atrial ischaemia.surgery

    Sinus bradycardia is common intra-operatively owing to manoeuvres that increase vagal tone, such

    as intubation. If intra-operative hypothermia is planned, sinus bradycardia will almost certainly

    occur. It may also occur after hydrogen peroxide irrigation during neurosurgery.

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-18http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-18http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-19http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-19http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-20http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-20http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-21http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-21http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-22http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-22http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-23http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-23http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-18http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-19http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-20http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-21http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-22http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-23
  • 7/27/2019 bradikard

    11/186

    Sinus bradycardia is also common postoperatively, mainly owing to pain, use of opioids, or the

    effects of the surgery itself.

    Bradycardia can be due to injury to the sinus node during heart-transplant surgery. Sinus node

    disease can become apparent after a Mustard procedure for transposition of the great arteries and

    repair of an atrial septal defect.

    AV block can occur after mitral valve and/or aortic valve surgery and after ventricular septal defect

    repair.hypothyroidism

    Sinus bradycardia is usually noted in patients with significant hypothyroidism, whether or not they

    have other symptoms of the disease, including signs and symptoms of congestive heart failure.[3]electrolyte disorders

    Hyperkalaemia, hypokalaemia, hypercalcaemia, and hypocalcaemia can cause bradycardia.

    Hyperkalaemia tends to be the most common abnormality seen; it causes bradycardia by causing a

    sinoventricular rhythm or AV block.[3]

    Should be screened for in all patients with bradycardia because they are easily correctable.

    infections

    Typhoid fever, diphtheria, tuberculosis, toxoplasmosis, rheumatic fever, viral myocarditis and Lyme

    disease have all been associated with bradycardia.exposure to toxins

    Lead exposure, black widow spider venom, and tricyclic antidepressant overdose have all been

    associated with bradycardia.infiltrative diseases

    Infiltrative disease, such as amyloidosis, Chagas' disease, or haemochromatosis, may also affect

    the conduction system of the heart, causing bradycardia.sleep apnoea

    Sinus node arrest, sinus bradycardia, and second-degree AV block are all manifestations of sleep

    apnoea.

    Diagnostic tests1st tests to ordershow all

    Test Result

    12-lead ECG may show sinus bradycardia with or without sinu

    block with junctional or ventricular escape, His-and AV block in a setting of myocardial infarcti

    precordium indicative of a neurological event m

    bradycardia

    Holter monitoring sinus pauses; sinus arrest; second- or third-degrewith symptoms

    event monitor sinus pauses; sinus arrest; second- or third-degrewith symptoms

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3
  • 7/27/2019 bradikard

    12/186

    exercise testing exercise-induced AV block; chronotropic incom

    carotid sinus massage pause of over 3 seconds with symptoms suggestof carotid sinus hypersensitivity

    echocardiogram underlying structural heart disease, such as ventrdisease

    thyroid function tests elevated TSH in hypothyroidism

    basic metabolic panel hypokalaemia or hyperkalaemia; hypocalcaemia

    cardiac markers elevation of CK, CK-MB, and troponin in myoc

    serum digoxin level depends on dose and drug-metabolism factors; m

    serum creatinine elevated

    Tests to considerhide all

    Test

    implantable-loop recorder

    Subcutaneous monitoring device used for the detection of cardiac arrhythmias.

    Typically implanted in the left parasternal or pectoral region.

    Useful modality if a patient has intermittent symptoms suspected to be secondary to a bradyarrhythmia b

    ECG abnormalities and negative Holter and/or event monitoring. Safe and efficacious in these settings.

    Device is implanted by an electrophysiologist and can be used for monitoring for up to 18 months.

    Stores recorded ECG strips either when the device is activated by the patient or when activated automa

    according to programmed threshold criteria. Periodic interrogation of the device can retrieve this informa

    Also useful to rule out bradyarrhythmia as a cause of the patient's symptoms by identifying normal sinus

    time of a symptom event of interest.

    Reduce/prevent recurrent symptoms.[29]

    May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or tachy

    syndrome) is suspected but cannot be documented.

    Particularly useful in diagnosing Mobitz I AV block.

    tilt-table testing

    Used to evaluate the adequacy of the autonomic system, especially when there is suspicion of neurocar

    syncope. Commonly used method is head-upright tilting, which causes dependent venous pooling and th

    provokes the autonomic response.

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29
  • 7/27/2019 bradikard

    13/186

    electrophysiology testing

    Recommended when symptoms cannot be correlated clearly and when significant bradyarrhythmias are

    cannot be diagnosed by non-invasive modalities.

    Testing can be useful in patients with AV block and no clear symptom association; in patients with symp

    bradycardia and in whom AV block is suspected but not documented; and when the site of AV block candetermined reliably by surface tracings.

    His-ventricle interval of >100 milliseconds in a patient with bradycardia, even in the absence of symptom

    risk finding.[31] [32]

    Overall, the role of electrophysiological testing for bradycardia is limited, owing to low sensitivity and spe

    Positive findings may not be the reason for symptoms.[33] [34]

    May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or tachy

    syndrome) is suspected but cannot be documented.

    Atrial pacing progressively shorter cycle lengths during an electrophysiology study can manifest Mobitz t

    subjects with normal or abnormal AV node conduction.

    Asymptomatic patients with Mobitz II AV block may benefit from this test to localise the site of block and

    therapy.

    Useful to demonstrate the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and hig

    block.

    Differential diagnosisCondition

    Differentiating

    signs/symptoms Differentiating tests

    Ventricular bigeminy Post-

    premature

    ventricular

    contraction

    (PVC)

    potentiation

    not present

    during sinus

    rhythm

    without PVCs.

    Cannon a-

    waves seen in

    ECG and rhythm strip correlated with pulse show a

    each normal beat.

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34
  • 7/27/2019 bradikard

    14/186

    the jugular

    venous pulse.

    Frequent premature ventricular

    contractions (PVCs) Non-perfused

    ventricularectopy

    causing

    apparent

    sinus

    bradycardia.

    Patients are

    usually

    asymptomatic

    .

    Cannon a-

    waves may be

    seen in the

    jugular

    venous pulse.

    ECG and rhythm strip correlated with pulse. Specif

    cause. However, ventricular beats occur earlier tha

    Atrial fibrillation Apical versus

    peripheral

    pulse.

    Irregular pulse

    rate.

    ECG shows absent P waves, presence of fibrillator

    complexes. Rhythm strip may be useful.

    Blocked premature atrial

    contractions (PACs) Atrial rate is

    fast but

    ventricular

    rate is slow.

    ECG shows slight notching on preceding T-wave.

    Ventricular tachycardia A-waves,

    variable S1,

    and variable

    pulse seen in

    ECG shows atrioventricular (AV) dissociation with c

    http://bestpractice.bmj.com/best-practice/monograph/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/537.htmlhttp://bestpractice.bmj.com/best-practice/monograph/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/537.html
  • 7/27/2019 bradikard

    15/186

    jugular

    venous

    pressure.

    Cardiac tamponade

    Muffled heartsounds.

    Sinus

    tachycardia.

    Pulsus

    paradoxus

    (usually below

    10 mmHg).

    Elevated

    jugular

    venous

    pressure.

    ECG shows low voltage, QRS, or total electrical alt

    Echocardiogram shows large pericardial effusion o

    respiratory variation of ventricular filling.

    Step-by-step diagnostic approachA diagnosis of bradycardia is simple and is generally made on an ECG or

    telemetry monitor when there is slowing of the heart rhythm to below 50 bpm,even if only transient. The challenge is determining the aetiology of thebradycardia and determining the site at which there is reduction in impulsegeneration or propagation. The primary use of testing is to correlatesymptoms with bradycardia and/or to establish a potentially dangerouscondition as the cause of bradycardia, even though the patient may beasymptomatic.

    History

    The most important diagnostic factor is age. Older patients present frequentlywith bradycardia owing to disease in the sinus node, the atrioventricular (AV)node, or the His-Purkinje system. In the AV conduction system, age-relatedfibrosis and sclerosis (Lenegre-Lev's disease) account for AV block in almosthalf of the cases. Older patients in particular may also present withbradycardia associated with medicines that have AV-node-blockingproperties, such as beta-blockers, calcium-channel blockers, and digoxin;therefore, a detailed drug history should be taken.

    http://bestpractice.bmj.com/best-practice/monograph/459.htmlhttp://bestpractice.bmj.com/best-practice/monograph/459.html
  • 7/27/2019 bradikard

    16/186

    A history of infection, infiltrative diseases, increased intracranial pressure,electrolyte disorders, exposure to toxins, surgery, heart transplant, sleepapnoea, or myocardial infarction may be present. Sinus bradycardia is usuallynoted in patients with significant hypothyroidism, whether or not they haveother symptoms of the disease. Asymptomatic or symptomatic sinus

    bradycardia may occur in association with hypothermia.

    One of the most common symptoms associated with bradycardia is dizzinessor lightheadedness. Many patients also complain of worsening fatigue.Syncope is possible with long pauses or slow heart rates, especially inpatients with complete heart block and a slow ventricular escape rhythm withleft ventricular dysfunction or in patients with second-degree AV block. Thesesymptoms generally occur owing to bradycardia-induced cerebralhypoperfusion, especially in the setting of left ventricular dysfunction.Exercise intolerance and shortness of breath is also common and may bedue to sinus node, AV node, or His-Purkinje system disease. Chest pain is arare presentation. Bradycardia can be asymptomatic, especially in youngerindividuals.

    Physical examinationExamination is usually non-specific. Palpation of peripheral pulse or cardiacauscultation may reveal a slow, regular heart beat of below 50 bpm or anirregular pulse of varying intensity.

    Patients with bradycardia secondary to complete heart block can haveintermittent cannon a-waves in their jugular venous pulse (JVP) owing toatrial contraction against a closed tricuspid valve. Similarly, there may be avariable S1 during complete AV block. During a junctional or ventricularrhythm with 1:1 V-to-A conduction, there may be cannon a-waves for eachheart beat.

    Because bradycardia can contribute to heart failure, patients may have a thirdheart sound, rales, jugular venous distension, and abdominal and lower

    extremity oedema. Signs of hypothyroidism should be assessed (e.g., dry orcoarse skin or hair, facial oedema). Poor cardiac output due to bradycardiamay be manifest as hypotension, mental status changes, and/or pallor; theextremities may be cool to the touch.

    ECG

  • 7/27/2019 bradikard

    17/186

    A 12-lead ECG is the first test in the diagnosis of bradycardia, regardless ofthe suspected cause. It is simple and easy to perform and providesdiagnostic information. ECG also offers important clues regarding underlyingconditions that could have caused the bradycardia; however, it only gives asnapshot in time that may not be helpful for diagnosis if bradycardia or

    symptoms are intermittent. In this situation, ambulatory monitoring is neededto correlate symptoms to bradycardia. ECG result depends on the cause ofbradycardia.

    Sinus node dysfunction

    Sinus bradycardia: regular P-wave followed by QRS at a rate of below 50 bpm; ambulatory ECG

    monitoring is helpful to correlate symptoms with heart rate.

    Sinus nodal pauses or arrest: long RR cycle length, which is longer than the RR interval of the

    underlying sinus rhythm. View image

    Sinus nodal exit block: an absent P-wave and prolongation of the RR cycle length, usually twice the

    underlying sinus RR interval.

    Tachy-brady syndrome: episodic periods of tachycardia (usually atrial flutter, atrial fibrillation, or atrial

    tachycardia), followed by termination of the tachycardia leading to sinus arrest or long sinus pauses, followed by

    sinus bradycardia.View imageView imageView imageView image

    AV conduction disturbance

    First-degree AV block: fixed prolongation of the PR interval over 0.2 seconds.[10] View image Second-degree AV block:

    o Mobitz I: grouped beating with a constant PP interval, lengthening in the PR interval and

    changing (usually shortening) RR intervals with the cycle ending with a P-wave not followed by a QRS complex.

    As the PR interval gradually prolongs, the RR interval tends to stay the same or shorten.[11] View imageView

    imageView image

    o Mobitz II: associated with single non-conducted P-waves with a constant PP interval and

    constant PR intervals (no change in the PR of over 0.025 seconds).[12] View imageView image

    o 2:1 AV block: only one PR interval to examine before the blocked P-wave and 2 P-waves for

    every QRS complex.View imageView image Block can be at the level of the AV node or the His-Purkinje system.

    If the QRS is narrow, the level of the block is probably in the AV node (which is more benign). If the QRS is wide

    (owing to bundle branch block or other conduction delay), block in the AV node is still most common but block in

    the His-Purkinje system is more frequent than when the QRS complex is narrow.

    o High-degree: more than one sequentially blocked P-wave. Block can be at the level of the AV

    node or the His-Purkinje system, as is the case with 2:1 AV block.

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/1.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/4.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/5.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/6.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/7.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/9.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/10.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/10.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/11.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/8.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/8.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/15.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/15.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/13.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/14.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/1.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/4.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/5.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/6.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/7.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/9.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/10.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/11.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/8.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/15.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/13.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/14.html
  • 7/27/2019 bradikard

    18/186

    Third-degree AV block: occurs when there are no conducted impulses from the atria to the ventricles;

    shows no consistent PR relationship.View imageView image May occur with ventricular or junctional escape

    rhythm.View imageView imageView image

    Paroxysmal AV block: normal AV nodal conduction followed by sudden block of AV conduction

    associated with a long pause and multiple blocked P-waves, with subsequent resumption of AV conduction.

    Vagotonic AV block: slowing of the sinus node with prolongation of the PR interval followed by AV block

    owing to transient abrupt increase in parasympathetic tone.

    Congenital complete heart block: usually associated with a narrow QRS complex escape rhythm arising

    in the AV node.

    Escape rhythms may also occur in AV block, such as atrial (abnormal P-wave and decreased PR

    interval), junctional (above the bundle of His, produces a rate of approximately 40 to 60 bpm and narrow QRS

    complexes) View imageand ventricular rhythms (below the bundle of His, produces a slower rate of 20 to 40

    bpm and wide QRS complexes).

    AV dissociation

    Independent activation of the atria and ventricles results in no fixedrelationship between the P-waves and the QRS complexes. The PR intervalsare variable in a random fashion. Ventricular rate is the same or faster thanthe atrial rate. There are 2 types:

    Isorhythmic: when the atrial rate is the same (or nearly the same as the ventricular rate) but the P-wave

    is not conducted.

    Interference: when P-waves and QRS rates are similar but, occasionally, the atria conduct to the

    ventricles.View imageView image

    Laboratory investigationsThere are no specific laboratory investigations used to diagnose bradycardia;however, initial work-up should include thyroid function tests and a completemetabolic panel to rule out electrolyte disturbances, particularly

    hyperkalaemia, hypokalaemia, hypercalcaemia, and hypocalcaemia. Cardiacenzymes should be obtained if bradycardia is associated with ECG changessuggestive of myocardial infarction or ischaemia. Patients who have

    junctional bradycardia and who are prescribed digoxin should have theirserum digoxin level checked. Patients with chronic bradycardia may haveevidence of worsening renal function. Any additional laboratory testing shouldbe guided by information obtained by history and physical examination to aididentification of the underlying cause.

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/16.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/17.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/18.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/19.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/2.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/20.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/20.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/21.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/16.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/17.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/18.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/19.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/2.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/20.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/21.html
  • 7/27/2019 bradikard

    19/186

    Other initial investigationsHolter or event monitoring, exercise testing, carotid sinus massage, andechocardiogram all form part of the initial work-up in addition to the ECG andare especially useful for intermittent bradycardia or patients with symptoms. Ifpatients have sinus bradycardia, they should be further evaluated only if theyare symptomatic or show evidence of haemodynamic compromise.

    Holter monitoring

    Enables correlation of symptoms with episodes of bradycardia. Diagnostic clues are obtained in 50% to

    70% of patients with bradycardia suspected on clinical grounds.[24] [25]However, events can be missed if

    symptoms do not occur in the 24- to 48-hour monitoring period.

    Asymptomatic bradycardia and pauses (especially nocturnal) are not uncommon in the normal heart and

    are probably non-diagnostic.

    Shows sinus pauses, sinus arrest, second- or third-degree AV block, or severe sinus bradycardia with

    symptoms. First-degree AV block or Mobitz type I AV block may be noted while patients are asleep owing to high

    vagal tone.

    May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or

    tachy-brady syndrome) is suspected but cannot be documented.

    May help distinguish the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and high-

    degree AV block. A long-monitored strip should be run because 2:1 AV block is unlikely to persist. The other

    forms of AV block (Mobitz I or II) should then become apparent. Monitoring while the patient does some form of

    exertion (e.g., arm exercise, standing, and walking) may also help to demonstrate the level of block. Block at the

    level of the AV node should improve with the adrenergic stimulation but block below the AV node in the His-

    Purkinje system may worsen as AV nodal conduction improves and increases the frequency of inputs to the His-

    Purkinje system.

    Event monitoring

    Widely used in the diagnosis of symptomatic bradycardia and can be worn for up to 30 days.

    Earlier designs were patient-triggered and so relied on the patient being able to recognise their

    symptoms and activate the monitor in a timely manner. This issue has been corrected to some extent by newer-

    generation monitors with auto-triggering capability and implantable loop recorders.

    Shows sinus pauses, sinus arrest, second- or third-degree AV block, or severe sinus bradycardia with

    symptoms. May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-25http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-25http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-25
  • 7/27/2019 bradikard

    20/186

    tachy-brady syndrome) is suspected but cannot be documented. Particularly useful in diagnosing Mobitz I AV

    block.

    Exercise testing

    A sub-normal increase in heart rate after exercise (chronotropic incompetence) can be useful in

    diagnosing sick sinus syndrome.[24] [26] However, sensitivity and specificity are unclear and the results

    obtained may not be reproducible.[27] Even so, exercise-induced AV block, even if asymptomatic, can be

    significant and suggests disease of the His-Purkinje system.

    Identifying symptoms owing to sinus bradycardia can be difficult; however, exercise testing can be useful

    to help determine sinus node dysfunction as the cause of symptoms.

    Useful in determining level of block in Mobitz I.

    Carotid sinus massage

    Used during continuous ECG monitoring (after evaluating for the presence of carotid bruit by direct

    auscultation) in the evaluation of carotid sinus hypersensitivity, which causes symptomatic bradycardia and is

    associated with sick sinus syndrome.

    Diagnostic yield of carotid sinus massage can be increased by performing this during head-up

    tilting.[28]

    A pause of over 3 seconds with symptoms is indicative of a cardio-inhibitory response from carotid sinus

    hypersensitivity.

    Can help diagnose Mobitz I and II AV block; it will accentuate Wenckebach in the AV node but will have

    an opposite effect if the block is below the His bundle.

    May help distinguish the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and high-

    degree AV block. It may improve block in the His-Purkinje system by slowing the sinus and AV nodal inputs to

    the His-Purkinje system, enabling the His-Purkinje system longer in which to recover between inputs.

    Echocardiogram

    Although it provides no direct diagnostic role for bradycardia, it provides valuable information regarding

    underlying heart disease that can influence management and decision making.Patients with significantly reduced

    left ventricular systolic function should be considered for an implantable cardioverter defibrillator if clinically

    appropriate.

    Further investigationsImplantable loop monitor

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-26http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-26http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-28http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-28http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-28http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-26http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-28
  • 7/27/2019 bradikard

    21/186

    A subcutaneous monitoring device used for the detection of cardiac arrhythmias. Typically implanted in

    the left parasternal or pectoral region.

    Useful modality if a patient has rare symptoms that are difficult to record with non-invasive tools such as

    ECG, Holter monitors, and/or event monitors due to their infrequent nature, but are suspected to be secondary to

    a bradyarrhythmia. Safe and efficacious in these settings.[29] [30] Also useful to rule out bradyarrhythmia as a cause of symptoms by identifying normal sinus rhythm at

    the time of a symptom event of interest.

    May show sinus pauses, sinus arrest, second- or third-degree AV block, or severe sinus bradycardia

    with symptoms. May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest,

    or tachy-brady syndrome) is suspected but cannot be documented. Particularly useful in diagnosing Mobitz I AV

    block.

    Tilt-table testing

    Used to evaluate adequacy of the autonomic system, especially when there is suspicion of

    neurocardiogenic syncope.

    A commonly used method is head-upright tilting, which causes dependent venous pooling and thereby

    provokes the autonomic response.

    Electrophysiological testing

    Recommended when symptoms cannot be correlated clearly and when significant bradyarrhythmias are

    suspected but cannot be diagnosed by non-invasive modalities.

    Electrophysiological measurements of sinus node function serve only as an adjunct to clinical and non-

    invasive parameters because these tests are based on assumptions that limit their validity and clinical utility.

    There is little utility for electrophysiology testing in already-documented second- and third-degree AV

    block. Testing can be useful in patients with AV block and no clear symptom association; in patients with

    symptoms of bradycardia in whom AV block is suspected but not documented; and when the site of AV block

    cannot be determined reliably by surface tracings.

    His-ventricle interval of over 100 milliseconds in a patient with bradycardia, even in the absence of

    symptoms, is a high-risk finding.[31] [32]

    Overall, the role of electrophysiological testing for bradycardia is limited, owing to low sensitivity and

    specificity. Positive findings may not be the reason for patient symptoms.[33][34]

    May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, tachy-

    brady syndrome) is suspected but cannot be documented.

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-30http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-30http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-30http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34
  • 7/27/2019 bradikard

    22/186

    Atrial pacing at progressively shorter cycle lengths during an electrophysiology study can manifest

    Mobitz type I in subjects with normal or abnormal AV node conduction.

    Asymptomatic patients with Mobitz II AV block may benefit from this test to localise the site of block and

    to guide therapy.

    Useful to demonstrate the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and

    high-degree AV block.

    Click to view diagnostic guideline references. Case history #1An 85-year-old man presents with fatigue and episodes during which he feelshe is going to pass out. He has no known heart disease. His ECG showssinus bradycardia with a rate of 30 bpm and on a rhythm strip he has up to 5-second pauses.

    Case history #2A 55-year-old man with hypertension and diabetes presents at theemergency department with complaints of dizziness and lightheadedness onexertion that has occurred gradually over the past month. He takesmetoprolol (a beta-blocker) for hypertension. He is hypotensive and has aheart rate of 45 bpm. The rhythm strip shows Mobitz type II atrioventricular(AV) block with Q waves in the inferior leads. There are no previous ECGs.

    Other presentationsOther diagnostic features include exercise intolerance and chest pain.

    Atypical presentations include elite athletes who present with sinusbradycardia, Mobitz I, or even Mobitz II atrioventricular (AV) block withoutsymptoms owing to a conditioned heart. The condition could also manifestshortly after taking a beta-blocker, calcium-channel blocker, or digoxin in apatient with conduction system disease. Adolescents may not have anysymptoms owing to preserved left-ventricular function; by contrast, older

    people are more likely to manifest symptoms because of structural heartdisease.

    Treatment Options

    http://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.html
  • 7/27/2019 bradikard

    23/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine. All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine: 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine: 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    2nd temporary pacing

    Patients who are not responsive to medical

    http://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-4&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-4&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-5&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-5&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-6&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-4&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-5&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-6&optionId=expsec-1&dd=MARTINDALE
  • 7/27/2019 bradikard

    24/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine.All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine : 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine : 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    haemodynamically stable: sinus

    http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37
  • 7/27/2019 bradikard

    25/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine. All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine : 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine : 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    node dysfunction

  • 7/27/2019 bradikard

    26/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine. All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine : 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine : 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    reversible cause: asymptomatic or1st treatment of underlying cause

  • 7/27/2019 bradikard

    27/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine. All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine : 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine : 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    mild symptoms For mild symptoms or when sinus node

  • 7/27/2019 bradikard

    28/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine. All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine : 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine : 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    dysfunction is a result of a reversible or isolated

  • 7/27/2019 bradikard

    29/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine. All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine : 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine : 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    cause (e.g., specific medicine, electrolyte disorder,

  • 7/27/2019 bradikard

    30/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmacotherapy

    In patients with systemic hypotension, signs of

    cerebral hypoperfusion, progressive heart failure,

    angina, or life-threatening ventricular

    tachyarrhythmia, medical therapy should be

    started immediately until temporary cardiac pacing

    is initiated.

    The most common medicines used to increase

    ventricular rate are intravenous atropine,

    epinephrine (adrenaline), or dopamine. All drugs

    are only marginally effective in providing sustained

    chronotropic support.

    Their efficacy is limited to patients with sinus node

    dysfunction or conduction abnormalities at the

    level of the atrioventricular (AV) node. However,

    patients with infranodal conduction system

    disease may demonstrate further worsening

    bradycardia.

    Dopamine should not be used in patients with life-

    threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart

    disease.

    Primary Options

    atropine : 0.5 to 1 mg intravenously as a bolus,

    repeat every 3-5 minutes as needed, maximum 3

    mg total dose

    Secondary Options

    epinephrine : 2-10 micrograms/min intravenous

    infusion, titrate rate according to response

    OR

    dopamine : 2-10 micrograms/kg/min intravenous

    infusion, titrate rate according to response

    or vasovagal event, such as taking blood),

  • 7/27/2019 bradikard

    31/186

    Patient group

    Treatment

    line Treatmenthide all

    haemodynamically unstable1st pharmac